TITLE

Estrogen plus progestin reduced the incidence of diabetes in postmenopausal women with coronary heart disease

AUTHOR(S)
Smith, Donald A.
PUB. DATE
September 2003
SOURCE
ACP Journal Club;Sep/Oct2003, Vol. 139 Issue 2, p39
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents a study that analyzed the effectiveness of estrogen plus progestin hormone replacement therapy in preventing an increase in fasting glucose level and reducing the incidence of diabetes in postmenopausal women with coronary heart disease. Design; Intervention; Outcome measures; Results; Commentary.
ACCESSION #
10987123

 

Related Articles

  • Hormone Replacement Therapy or Prophylaxis in Postmenopausal Women with Recurrent Urinary Tract Infection. Raz, Raul // Journal of Infectious Diseases;3/2/2001 Supplement 1, Vol. 183, pS74 

    Presents information on a study which examined the use of prolonged estrogen therapy in preventing urinary tract infection in postmenopausal women. Difficulties in vaginal therapy; Indications and contraindications for estrogen therapy; Commentary.

  • CIMICIFUGA RACEMOSA ALTERS BEHAVIOR AND PVN C-FOS EXPRESSION IN OVARIECTOMIZED RATS SUBJECTED TO THE FORCED SWIMMING TEST. Hu, G. M.; Shen, G. M.; Xu, H. // Acta Endocrinologica (1841-0987);Oct-Dec2012, Vol. 8 Issue 4, p529 

    Background: Cimicifuga racemosa (CR) is widely used in the treatment of menopausal symptoms, including hormonerelated affective disorders in women. Mechanistic studies suggest that unlike hormone-replacement therapy, CR does not stimulate cancerous growth. Objective: to evaluate CR safety and...

  • Trial results refute cardiac benefit of estrogen-progestin.  // Geriatrics;Oct98, Vol. 53 Issue 10, p15 

    Reports that according to researchers from the Heart and estrogen/progestin Replacement Study (HERS), the combination therapy of estrogen-progestin does not reduce the risk of heart attack and other coronary events in postmenopausal women who have coronary heart disease. Information on the...

  • SHOULD YOU TAKE ESTROGEN? Perlmutter, C. // Prevention;Nov89, Vol. 41 Issue 11, p42 

    This article discusses the risks and benefits of undergoing hormone-replacement therapy (HRT) at menopause. Alternatives to HRT are also discussed. HRT usually involves a regular program of estrogen to replace the natural estrogen that wanes at menopause. Sometimes, another hormone, progesterone...

  • Prescribing menopausal hormone therapy: an evidence-based approach. Sood, Richa; Faubion, Stephanie S.; Kuhle, Carol L.; Thielen, Jacqueline M.; Shuster, Lynne T. // International Journal of Women's Health;2014, Vol. 6, p47 

    The constantly changing landscape regarding menopausal hormone therapy (MHT) has been challenging for providers caring for menopausal women. After a decade of fear and uncertainty regarding MHT, reanalysis of the Women's Health Initiative data and the results of recent studies have provided some...

  • Estrogen did not prevent death or nonfatal stroke in postmenopausal women with ischemic stroke or TIA. McNagny, Sally E. // ACP Journal Club;May/Jun2002, Vol. 136 Issue 3, p96 

    Comments on a study which investigated a clinical trial of estrogen-replacement therapy after ischemic stroke. Outcome measures; Effectiveness of estrogen and placebo in preventing death or nonfatal stroke on postmenopausal women with ischemic stroke or transient ischemic attack; Information on...

  • Estrogen for Younger Postmenopausal Women. Elliott, William T. // Clinical Oncology Alert;Aug2007 Pharmacology Watch, p2 

    The article provides information on a study from the Women's Health Initiative which suggested that estrogen therapy in younger postmenopausal women may be of benefit in preventing cardiovascular disease. The study concluded that in women age 50 to 59 years old at enrollment, estrogen treatment...

  • Oral estrogen therapy in postmenopausal women is associated with loss of kidney function. Ahmed, Sofia B.; Culleton, Bruce F.; Tonelli, Marcello; Klarenbach, Scott W.; MacRae, Jennifer M.; Jianguo Zhang; Hemmelgarn, Brenda R. // Kidney International;Aug2008, Vol. 74 Issue 3, p370 

    Women are generally protected against progressive loss of kidney function; however, this advantage seems to diminish with menopause. Because of conflicting reports on the association between use of hormone therapy and kidney function we studied 5845 women (1459 on hormone therapy and 4386...

  • Management of the menopause: integrated health-care pathway for the menopausal woman. Rees, Margaret // Menopause International;Jun2011, Vol. 17 Issue 2, p50 

    Management of the menopausal woman has become controversial since publication of the results of the Women's Health Initiative and the Million Women Study from 2002 onwards. This health-care pathway summarizes the role of hormone replacement therapy and non-estrogen-based treatments as well as...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics